PharmaTimesNews & Politicsnews

NICE recommends MSD’s pembrolizumab for locally advanced cervical cancer

Thursday, June 25, 2026John PinchingView original

First immunotherapy approved for LACC in England offers new treatment option for women

Read the full article on the original site.